Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP170925.RAFF9cB58Ocy5QXaVTi1k6Mi3lERF76cwagpwLiIotrUg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP170925.RAFF9cB58Ocy5QXaVTi1k6Mi3lERF76cwagpwLiIotrUg130_assertion type Assertion NP170925.RAFF9cB58Ocy5QXaVTi1k6Mi3lERF76cwagpwLiIotrUg130_head.
- NP170925.RAFF9cB58Ocy5QXaVTi1k6Mi3lERF76cwagpwLiIotrUg130_assertion description "[Thirty-three of 215 (15%) women with ASC-US and oncogenic HPV who underwent histological sampling demonstrated CIN 2 or 3.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP170925.RAFF9cB58Ocy5QXaVTi1k6Mi3lERF76cwagpwLiIotrUg130_provenance.
- NP170925.RAFF9cB58Ocy5QXaVTi1k6Mi3lERF76cwagpwLiIotrUg130_assertion evidence source_evidence_literature NP170925.RAFF9cB58Ocy5QXaVTi1k6Mi3lERF76cwagpwLiIotrUg130_provenance.
- NP170925.RAFF9cB58Ocy5QXaVTi1k6Mi3lERF76cwagpwLiIotrUg130_assertion SIO_000772 16829752 NP170925.RAFF9cB58Ocy5QXaVTi1k6Mi3lERF76cwagpwLiIotrUg130_provenance.
- NP170925.RAFF9cB58Ocy5QXaVTi1k6Mi3lERF76cwagpwLiIotrUg130_assertion wasDerivedFrom befree-20140225 NP170925.RAFF9cB58Ocy5QXaVTi1k6Mi3lERF76cwagpwLiIotrUg130_provenance.
- NP170925.RAFF9cB58Ocy5QXaVTi1k6Mi3lERF76cwagpwLiIotrUg130_assertion wasGeneratedBy ECO_0000203 NP170925.RAFF9cB58Ocy5QXaVTi1k6Mi3lERF76cwagpwLiIotrUg130_provenance.